(Q35112457)

6 August 2017

title

Pharmacokinetics of factor VIII and factor IX (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

26 December 2023

1 reference

M. Morfini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709044

26 December 2023

language of work or name

1 reference

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.9.s1.8.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.9.s1.8.x

26 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

26 December 2023

1 reference

6 August 2017

volume

9 Suppl 1

1 reference

6 August 2017

page(s)

94-9; discussion 100

1 reference

PKRD: a pharmacokinetic program for least-squares and bayesian analysis of repeated-dose pharmacokinetic curves.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.8.X

Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.8.X

Discrepancies in potency assessment of recombinant FVIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.8.X

Influence of phospholipids on the assessment of factor VIII activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.8.X

In vivo recovery with products of very high purity--assay discrepancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.8.X

Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Clinical pharmacokinetics of factor VIII in patients with classic haemophilia

26 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs

26 December 2023

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies

26 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation

26 December 2023

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia A

26 December 2023

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Pharmacokinetics of two pasteurized Factor VIII concentrates by different and multicenter assays of Factor VIII activity

26 December 2023

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group

26 December 2023

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate

26 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Comparative evaluation of the pharmacokinetics of three monoclonal factor VIII concentrates

26 December 2023

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations

26 December 2023

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

A calculator program for clinical application of the Bayesian method of predicting plasma drug levels

26 December 2023

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Discrepancy between one-stage and two-stage assay of factor VIII:C

26 December 2023

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Potency of high purity factor VIII concentrates

26 December 2023

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

The behaviour of different factor VIII concentrates in a chromogenic factor X-activating system

26 December 2023

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Activated coagulation factors: in-vivo and in-vitro studies

26 December 2023

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

Clotting factor concentrates in clinical practice. Standardization and assay

26 December 2023

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.8.X

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference